Skip to main content

Table 4 Biochemical parameters

From: Effects of lornoxicam on the physiology of severe sepsis

Parameter Baseline Hours after the start of infusion
   24 48 72
Lactate (mg/dl)     
Lornoxicam 25.2 ± 4.1 25.0 ± 3.9 25.9 ± 5.2 26.2 ± 3.7
Placebo 26.3 ± 3.8 26.7 ± 2.9 27.0 ± 3.1 26.9 ± 4.8
Platelets (×109/l)     
Lornoxicam 192.9 ± 16.5 193.5 ± 15.0 178.1 ± 15.4 182.9 ± 15.6
Placebo 188.5 ± 14.4 190.8 ± 15.1 188.7 ± 13.3 190.5 ± 16.7
Leucocytes (×109/l)     
Lornoxicam 14 ± 8.3 15.8 ± 8.3 16.0 ± 7.8 15.9 ± 6.2
Placebo 13.5 ± 6.6 14.7 ± 4.7 15.7 ± 6.7 14.8 ± 7.4
Bilirubin (mg/dl)     
Lornoxicam 0.89 ± 0.38 0.90 ± 0.45 0.93 ± 0.33 0.90 ± 0.34
Placebo 0.90 ± 0.62 0.91 ± 0.38 0.92 ± 0.28 0.91 ± 0.36
Alanine aminotransferase (IU/l)     
Lornoxicam 35.4 ± 5.5 36.0 ± 10.8 35.1 ± 8.6 36.7 ± 8.4
Placebo 35.4 ± 7.4 35.5 ± 5.2 36.2 ± 6.0 37.4 ± 4.9
Creatinine (mg/dl)     
Lornoxicam 1.13 ± 0.96 1.15 ± 0.85 1.2 ± 0.3 1.28 ± 0.8
Placebo 1.01 ± 0.91 1.1 ± 0.65 1.08 ± 0.7 1.1 ± 0.8
  1. No significant differences were found between groups. Data are expressed as mean ± standard deviation.